Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

✍ Scribed by Moore, M. J.; Goldstein, D.; Hamm, J.; Figer, A.; Hecht, J. R.; Gallinger, S.; Au, H. J.; Murawa, P.; Walde, D.; Wolff, R. A.; Campos, D.; Lim, R.; Ding, K.; Clark, G.; Voskoglou-Nomikos, T.; Ptasynski, M.; Parulekar, W.

• Book ID: 125531660
• Publisher: American Society of Clinical Oncology
• Year: 2007
• Tongue: English
• Weight: 357 KB
• Volume: 25
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2006.07.9525